These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28825670)

  • 1. Further Evidence of a Specific Psychopathology of Addiction. Differentiation from Other Psychiatric Psychopathological Dimensions (Such as Obesity).
    Maremmani AGI; Cerniglia L; Cimino S; Bacciardi S; Rovai L; Pallucchini A; Spera V; Perugi G; Maremmani I
    Int J Environ Res Public Health; 2017 Aug; 14(8):. PubMed ID: 28825670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
    Maremmani AGI; Gazzarrini D; Fiorin A; Cingano V; Bellio G; Perugi G; Maremmani I
    Ann Gen Psychiatry; 2018; 17():3. PubMed ID: 29371875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a psychopathology specific to Substance Use Disorder: Should emotional responses to life events be included?
    Maremmani AGI; Maiello M; Carbone MG; Pallucchini A; Brizzi F; Belcari I; Conversano C; Perugi G; Maremmani I
    Compr Psychiatry; 2018 Jan; 80():132-139. PubMed ID: 29091779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment.
    Maremmani AG; Pani PP; Trogu E; Vigna-Taglianti F; Mathis F; Diecidue R; Kirchmayer U; Amato L; Ghibaudi J; Camposeragna A; Saponaro A; Davoli M; Faggiano F; Maremmani I
    Ann Gen Psychiatry; 2016; 15():29. PubMed ID: 27833645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the migration process influence the clinical expression of heroin use disorder in migrants to Italy?
    Maremmani I; Carbone MG; Tagliarini C; Ricci M; Lupi AM; Sarandrea L; Ceban A; Maremmani AGI; Casella P
    CNS Spectr; 2021 Feb; 26(1):62-70. PubMed ID: 31969204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment.
    Pani PP; Trogu E; Vigna-Taglianti F; Mathis F; Diecidue R; Kirchmayer U; Amato L; Davoli M; Ghibaudi J; Camposeragna A; Saponaro A; Faggiano F; Maremmani AG; Maremmani I
    Ann Gen Psychiatry; 2014; 13(1):35. PubMed ID: 25435897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?
    Pani PP; Maremmani AG; Trogu E; Vigna-Taglianti F; Mathis F; Diecidue R; Kirchmayer U; Amato L; Ghibaudi J; Camposeragna A; Saponaro A; Davoli M; Faggiano F; Maremmani I
    Ann Gen Psychiatry; 2016; 15():13. PubMed ID: 27118983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward the Identification of a Specific Psychopathology of Substance Use Disorders.
    Maremmani AGI; Pani PP; Rovai L; Bacciardi S; Maremmani I
    Front Psychiatry; 2017; 8():68. PubMed ID: 28496418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90).
    Maremmani I; Pani PP; Pacini M; Bizzarri JV; Trogu E; Maremmani AG; Gerra G; Perugi G; Dell'Osso L
    Ann Gen Psychiatry; 2010 Apr; 9():15. PubMed ID: 20388223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment.
    Della Rocca F; Maremmani AGI; Bacciardi S; Pacini M; Lamanna F; Tripodi B; Miccoli M; Maremmani I
    Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Exploratory Study on the Influence of Psychopathological Risk and Impulsivity on BMI and Perceived Quality of Life in Obese Patients.
    Tambelli R; Cerniglia L; Cimino S; Ballarotto G; Paciello M; Lubrano C; Marchitelli S; Gnessi L; Lenzi A
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28445437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bulimic behaviours and psychopathology in obese adolescents and in their parents.
    Isnard P; Quantin L; Cortese S; Falissard B; Musher-Eizenman D; Guedeney A; Frelut ML; Mouren MC
    Int J Pediatr Obes; 2010 Dec; 5(6):474-82. PubMed ID: 20233146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obesity, alexithymia, psychopathology and binge eating: a comparative study of 40 obese patients and 32 controls].
    De Chouly De Lenclave MB; Florequin C; Bailly D
    Encephale; 2001; 27(4):343-50. PubMed ID: 11686056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposed effects of hyperthymic and cyclothymic temperament in substance use disorder (heroin- or alcohol-dependent patients).
    Rovai L; Maremmani AGI; Bacciardi S; Gazzarrini D; Pallucchini A; Spera V; Perugi G; Maremmani I
    J Affect Disord; 2017 Aug; 218():339-345. PubMed ID: 28494392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of binge eating disorder in the psychopathological profile of obese women.
    Fandiño J; Moreira RO; Preissler C; Gaya CW; Papelbaum M; Coutinho WF; Appolinario JC
    Compr Psychiatry; 2010; 51(2):110-4. PubMed ID: 20152289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eating disorder psychopathology does not predict the overweight severity in subjects seeking weight loss treatment.
    Castellini G; Lapi F; Ravaldi C; Vannacci A; Rotella CM; Faravelli C; Ricca V
    Compr Psychiatry; 2008; 49(4):359-63. PubMed ID: 18555056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and psychological correlates of health-related quality of life in obese patients.
    Mannucci E; Petroni ML; Villanova N; Rotella CM; Apolone G; Marchesini G;
    Health Qual Life Outcomes; 2010 Aug; 8():90. PubMed ID: 20731871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
    Maremmani AG; Rovai L; Pani PP; Pacini M; Lamanna F; Rugani F; Schiavi E; Dell'osso L; Maremmani I
    Ann Gen Psychiatry; 2011 May; 10():17. PubMed ID: 21569624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopathological similarities and differences between obese patients seeking surgical and non-surgical overweight treatments.
    Castellini G; Godini L; Amedei SG; Galli V; Alpigiano G; Mugnaini E; Veltri M; Rellini AH; Rotella CM; Faravelli C; Lucchese M; Ricca V
    Eat Weight Disord; 2014 Mar; 19(1):95-102. PubMed ID: 24014259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopathological and psychiatric evaluation of patients affected by lipodystrophy.
    Calabrò PF; Ceccarini G; Calderone A; Lippi C; Piaggi P; Ferrari F; Magno S; Pedrinelli R; Santini F
    Eat Weight Disord; 2020 Aug; 25(4):991-998. PubMed ID: 31144218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.